Novo, GSK, CRISPR, Prime, COPD
Wish to keep on high of the science and politics driving biotech at present? Join to get our biotech publication in your ...
Tag: CRISPR
Scientists call for 10-year ban on CRISPR for germline gene editing
Megan Molteni stories on discoveries from the frontiers of genomic drugs, neuroscience, and reproductive tech. She joined STAT in 2021 ...
Federal court reopens question of who owns key CRISPR patents
Megan Molteni reviews on discoveries from the frontiers of genomic medication, neuroscience, and reproductive tech. She joined STAT in 2021 ...
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies
Caribou Biosciences’ 2025 outlook aimed for key trial readouts for 2 most cancers cell therapies within the first half of ...
CRISPR stocks, FDA staff cuts, Bluebird Bio
Wish to keep on prime of the science and politics driving biotech in the present day? Enroll to get our biotech publication ...
Intellia says CRISPR therapy showed gains in cardiomyopathy
Intellia Therapeutics CEO John Leonard has, for the final couple years, discovered himself caught in a monetary Groundhog Day. Repeatedly, ...
CRISPR babies scientist moves to Chinese medical tourism hub
Jiankui He, the Chinese language scientist who sparked a worldwide uproar in 2018 when he revealed he had created the ...
RECOMMENDED
Why Intermountain Health Is Investing In AI for Clinical Data Abstraction
Intermountain Well being, the most important nonprofit healthcare supplier within the Intermountain West area, struck a multi-year collaboration with a...
Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.